Skip to main content

Table 2 Univariate predictors of ICU survival*

From: Should highly active antiretroviral therapy be prescribed in critically ill HIV-infected patients during the ICU stay? A retrospective cohort study

Characteristics Non survivors n = 17 (19) Survivors n = 74 (81) p
Characteristics at ICU admission    
Age (in years) 40 ± 9 43 ± 10 0.13
Sex (M/F) 7/10 23/51 0.57
Glasgow score 8 ± 5 13 ± 4 0.0003
HIV infection    
Initial HIV diagnosis 7 (37) 10 (14) 0.015
Stage C 13 (76) 56 (76) 0.99
CD4 count at admission (cells/mm3) 120 ± 98 206 ± 209 0.38
AIDS related diagnosis at ICU admission 11 (65) 35 (47) 0.28
Care in ICU    
Mechanical ventilation 17 (100) 28 (38) <0.0001
Duration of ventilation (days) 12 ± 13 4 ± 9 <0.0001
Vasoactive drugs 5 (29) 8 (11) 0.06
Duration of vasoactive drugs use (days) 2.5 ± 2.7 0.7 ± 1.7 <0.0001
Use of HAART    
HAART at ICU admission 6 (38) 46 (62) 0.09
§ immunovirological success at ICU admission 2 (12) 19 (26) 0.34
HAART during ICU stay 5 (29) 27 (36) 0.78
  1. *Data are presented as No. (%) or mean ± SD. §Immunovirological success was defined as viral load < 200 copies/ml and CD4 > 200 cells/mm3.